190:@0.085219:0.957873:0.109687:0.957873:0.109687:0.938882:0.085219:0.938882:0.007284:0.008593:0.008591
ADDENDUM:@0.117647:0.067543:0.201421:0.067543:0.201421:0.045457:0.117647:0.045457:0.009679:0.010295:0.010295:0.008697:0.010706:0.010295:0.010226:0.013582
cers. JCI Insight 2, e89760 (2017).:@0.155000:0.119718:0.411737:0.119718:0.411737:0.101197:0.155000:0.101197:0.008176:0.008218:0.006931:0.006973:0.004088:0.003735:0.006080:0.013343:0.006599:0.003735:0.006267:0.010561:0.006912:0.005105:0.009025:0.010085:0.005852:0.003735:0.009483:0.004088:0.003735:0.008218:0.009483:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
112. Harris, F. R. :@0.117647:0.140297:0.247739:0.140297:0.247739:0.121776:0.117647:0.121776:0.009483:0.009483:0.009483:0.004088:0.004814:0.014713:0.008259:0.007097:0.007097:0.005105:0.006973:0.004088:0.003569:0.007906:0.004088:0.003569:0.012451:0.004088:0.003735
et al.:@0.247550:0.140297:0.282504:0.140297:0.282504:0.121585:0.247550:0.121585:0.007346:0.005727:0.003640:0.009048:0.004607:0.004586
 Targeting HER2 in patient-derived xenograft ovarian cancer models sensi-:@0.282505:0.140297:0.852941:0.140297:0.852941:0.121776:0.282505:0.121776:0.003569:0.009917:0.008261:0.006931:0.008778:0.008301:0.005852:0.005105:0.010417:0.008965:0.003569:0.015315:0.010998:0.012160:0.009483:0.003569:0.005105:0.010687:0.003569:0.010334:0.008010:0.005852:0.005043:0.008218:0.010355:0.005852:0.006848:0.010293:0.008218:0.007097:0.005043:0.008757:0.008280:0.010355:0.003569:0.008985:0.008218:0.010542:0.010044:0.008965:0.007178:0.008259:0.005634:0.005634:0.003569:0.009878:0.008944:0.008259:0.007097:0.005271:0.008259:0.010687:0.003569:0.008280:0.008261:0.010542:0.008176:0.008218:0.007097:0.003569:0.015896:0.010251:0.010293:0.008135:0.004773:0.006973:0.003569:0.007159:0.008218:0.010563:0.006910:0.005038:0.006848
tizes tumors to chemotherapy. Mol. Oncol. 13, 132–152 (2019).:@0.155000:0.160875:0.636915:0.160875:0.636915:0.142355:0.155000:0.142355:0.005852:0.005105:0.008031:0.008218:0.006973:0.003735:0.005603:0.010376:0.015896:0.009857:0.006931:0.006973:0.003735:0.005644:0.010044:0.003735:0.007969:0.010272:0.008218:0.015896:0.009836:0.006018:0.010272:0.008218:0.007180:0.008010:0.010085:0.007263:0.004088:0.003735:0.017243:0.009940:0.004524:0.004088:0.003735:0.014817:0.010544:0.008176:0.009940:0.004524:0.004088:0.003735:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
113. Guffanti, F. :@0.117647:0.181454:0.243721:0.181454:0.243721:0.162933:0.117647:0.162933:0.009483:0.009483:0.009483:0.004088:0.004814:0.013883:0.010376:0.005427:0.005427:0.008259:0.010355:0.005852:0.004856:0.004088:0.004470:0.007906:0.004088:0.003735
et al.:@0.244457:0.181454:0.280337:0.181454:0.280337:0.162742:0.244457:0.162742:0.007346:0.005727:0.004565:0.009048:0.004607:0.004586
 Platinum sensitivity and DNA repair in a recently established panel of pa-:@0.280341:0.181454:0.852941:0.181454:0.852941:0.162933:0.280341:0.162933:0.004470:0.010749:0.004939:0.008010:0.005852:0.005105:0.010355:0.010376:0.016041:0.004470:0.007159:0.008218:0.010563:0.006910:0.004794:0.005852:0.005043:0.008944:0.004794:0.005852:0.008840:0.004470:0.008259:0.010544:0.010355:0.004470:0.014339:0.014007:0.013572:0.004470:0.006765:0.008301:0.010334:0.008259:0.005105:0.007097:0.004470:0.005105:0.010687:0.004472:0.008446:0.004470:0.006765:0.008280:0.008176:0.008218:0.010355:0.006018:0.004711:0.008840:0.004470:0.008218:0.006827:0.005956:0.008280:0.009919:0.004773:0.005105:0.006869:0.010272:0.008280:0.010355:0.004470:0.010334:0.008259:0.010544:0.008135:0.004773:0.004470:0.009857:0.005644:0.004470:0.010334:0.008445:0.006848
tient-derived ovarian carcinoma xenografts. Oncotarget 9, 24707–24717 (2018).:@0.155000:0.202033:0.766901:0.202033:0.766901:0.183512:0.155000:0.183512:0.005852:0.005043:0.008218:0.010355:0.005852:0.006848:0.010293:0.008218:0.007097:0.005043:0.008757:0.008280:0.010355:0.003735:0.009878:0.008944:0.008259:0.007097:0.005269:0.008259:0.010687:0.003735:0.008280:0.008259:0.006765:0.008176:0.005105:0.010542:0.009859:0.015979:0.008446:0.003735:0.008983:0.008218:0.010544:0.010044:0.008965:0.007178:0.008259:0.005634:0.005634:0.006973:0.004088:0.003735:0.014817:0.010542:0.008176:0.009836:0.005956:0.008259:0.006931:0.008778:0.008301:0.005852:0.003735:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
114. Hidalgo, M. :@0.117647:0.222612:0.251101:0.222612:0.251101:0.204091:0.117647:0.204091:0.009483:0.009483:0.009483:0.004088:0.004814:0.014983:0.005043:0.010521:0.008550:0.004773:0.008778:0.009338:0.004088:0.004379:0.017826:0.004088:0.003735
et al.:@0.251749:0.222612:0.287545:0.222612:0.287545:0.203900:0.251749:0.203900:0.007346:0.005727:0.004482:0.009048:0.004607:0.004586
 Patient-derived xenograft models: an emerging platform for translational :@0.287541:0.222612:0.856654:0.222612:0.856654:0.204091:0.287541:0.204091:0.004379:0.010376:0.008010:0.005852:0.005043:0.008218:0.010355:0.005852:0.006848:0.010293:0.008218:0.007097:0.005043:0.008757:0.008280:0.010355:0.004379:0.008985:0.008218:0.010544:0.010044:0.008965:0.007178:0.008259:0.005634:0.005634:0.004379:0.015896:0.010251:0.010293:0.008135:0.004773:0.006973:0.004088:0.004379:0.008259:0.010687:0.004379:0.008218:0.015896:0.008218:0.006931:0.008965:0.005105:0.010417:0.008965:0.004379:0.010148:0.004939:0.008010:0.005852:0.005478:0.009857:0.007097:0.016041:0.004379:0.005478:0.009857:0.007097:0.004379:0.005852:0.007180:0.008259:0.010563:0.006869:0.004939:0.008010:0.005852:0.005043:0.009857:0.010625:0.008550:0.004773:0.003735
cancer research. Cancer Discov. 4, 998–1013 (2014).:@0.155000:0.243190:0.553637:0.243190:0.553637:0.224669:0.155000:0.224669:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.003735:0.006765:0.008218:0.007159:0.008446:0.008259:0.006765:0.007969:0.010417:0.004088:0.003735:0.013611:0.008259:0.010544:0.008176:0.008218:0.007097:0.003735:0.014566:0.005105:0.007159:0.008176:0.009878:0.007367:0.004088:0.003735:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
115. Ben-David, U. :@0.117647:0.263769:0.270273:0.263769:0.270273:0.245248:0.117647:0.245248:0.009483:0.009483:0.009483:0.004088:0.004814:0.011891:0.008218:0.010687:0.006848:0.014732:0.008116:0.008944:0.005041:0.010106:0.004088:0.006142:0.012638:0.004088:0.003735
et al.:@0.272661:0.263769:0.310243:0.263769:0.310243:0.245057:0.272661:0.245057:0.007346:0.005727:0.006267:0.009048:0.004607:0.004586
 Patient-derived xenografts undergo mouse-specific tumor evolution. :@0.310243:0.263769:0.856686:0.263769:0.856686:0.245248:0.310243:0.245248:0.006132:0.010376:0.008010:0.005852:0.005043:0.008218:0.010355:0.005852:0.006848:0.010293:0.008218:0.007097:0.005043:0.008757:0.008280:0.010355:0.006132:0.008985:0.008218:0.010542:0.010044:0.008965:0.007180:0.008259:0.005634:0.005634:0.006973:0.006132:0.010376:0.010544:0.010293:0.008218:0.006929:0.008780:0.010044:0.006132:0.015896:0.009836:0.010376:0.007159:0.008218:0.006848:0.006827:0.010457:0.008280:0.008176:0.005105:0.005167:0.005105:0.008176:0.006132:0.005603:0.010376:0.015896:0.009857:0.007097:0.006142:0.008487:0.008757:0.009940:0.004462:0.010065:0.005852:0.005043:0.009857:0.010687:0.004088:0.003735
Nat. Genet. 49, 1567–1575 (2017).:@0.155000:0.284348:0.417695:0.284348:0.417695:0.265827:0.155000:0.265827:0.014132:0.008010:0.005852:0.004088:0.003735:0.014381:0.008218:0.010542:0.008301:0.005852:0.004088:0.003735:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
116. Woo, X. Y. :@0.117647:0.304926:0.237405:0.304926:0.237405:0.286406:0.117647:0.286406:0.009483:0.009483:0.009483:0.004088:0.004814:0.016954:0.010251:0.009338:0.004088:0.003735:0.012825:0.004088:0.003735:0.009566:0.004088:0.003735
et al.:@0.237418:0.304926:0.272551:0.304926:0.272551:0.286214:0.237418:0.286214:0.007346:0.005727:0.003818:0.009048:0.004607:0.004586
 Conservation of copy number profiles during engraftment and passaging of :@0.272555:0.304926:0.856630:0.304926:0.856630:0.286406:0.272555:0.286406:0.003735:0.013634:0.009857:0.010563:0.007159:0.008218:0.007637:0.008944:0.008010:0.005852:0.005043:0.009857:0.010687:0.003735:0.009857:0.005644:0.003735:0.008176:0.009836:0.010083:0.008840:0.003735:0.010355:0.010376:0.015813:0.010231:0.008218:0.007097:0.003735:0.010065:0.006765:0.009857:0.005167:0.005292:0.004711:0.008218:0.006973:0.003735:0.010044:0.010376:0.007097:0.005105:0.010417:0.008965:0.003735:0.008218:0.010417:0.008965:0.007180:0.008259:0.005634:0.005634:0.015898:0.008218:0.010355:0.005852:0.003735:0.008259:0.010542:0.010355:0.003735:0.010334:0.008446:0.006848:0.007222:0.008363:0.008965:0.005105:0.010417:0.008965:0.003735:0.009857:0.005644:0.003735
patient-derived cancer xenografts. bioRxiv (2020) doi:10.1101/861393.:@0.155000:0.325505:0.695882:0.325505:0.695882:0.306984:0.155000:0.306984:0.010334:0.008010:0.005852:0.005043:0.008218:0.010355:0.005852:0.006848:0.010293:0.008218:0.007097:0.005043:0.008757:0.008280:0.010355:0.003735:0.008278:0.008259:0.010542:0.008176:0.008218:0.007097:0.003735:0.008985:0.008218:0.010542:0.010044:0.008965:0.007180:0.008259:0.005634:0.005634:0.006973:0.004088:0.003735:0.009836:0.005043:0.010044:0.012160:0.009172:0.005043:0.008944:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.003733:0.010293:0.009857:0.005105:0.004088:0.009483:0.009483:0.004088:0.009483:0.009483:0.009483:0.009483:0.006454:0.009483:0.009483:0.009483:0.009483:0.009483:0.009479:0.004088
117. Sato, T. :@0.117647:0.346084:0.212855:0.346084:0.212855:0.327563:0.117647:0.327563:0.009483:0.009483:0.009483:0.004088:0.004814:0.009193:0.008010:0.005644:0.009338:0.004088:0.003798:0.009961:0.004088:0.003735
et al.:@0.212918:0.346084:0.248115:0.346084:0.248115:0.327372:0.212918:0.327372:0.007346:0.005727:0.003881:0.009050:0.004607:0.004586
 Single Lgr5 stem cells build crypt-villus structures :@0.248113:0.346084:0.636105:0.346084:0.636105:0.327563:0.248113:0.327563:0.003798:0.009193:0.005105:0.010417:0.009027:0.004711:0.008218:0.003798:0.010563:0.008965:0.007097:0.009483:0.003798:0.006827:0.005644:0.008218:0.016041:0.003798:0.008176:0.008135:0.004897:0.004773:0.006973:0.003798:0.009816:0.010376:0.005229:0.004711:0.010355:0.003798:0.008176:0.007635:0.008840:0.010044:0.005852:0.006848:0.008944:0.005229:0.004897:0.004462:0.010376:0.006973:0.003798:0.006827:0.005852:0.007242:0.010314:0.008280:0.005603:0.010376:0.006765:0.008218:0.006973:0.003735
in vitro:@0.636168:0.346084:0.689126:0.346084:0.689126:0.327372:0.636168:0.327372:0.004628:0.010272:0.003881:0.008446:0.004731:0.005333:0.006641:0.009027
 without a mesenchy-:@0.689127:0.346084:0.852941:0.346084:0.852941:0.327563:0.689127:0.327563:0.003798:0.013385:0.004794:0.006018:0.010272:0.009836:0.010065:0.005852:0.003798:0.008446:0.003798:0.015896:0.008218:0.007159:0.008218:0.010542:0.007969:0.010065:0.008841:0.006848
mal niche. Nature 459, 262–265 (2009).:@0.155000:0.366663:0.456895:0.366663:0.456895:0.348142:0.155000:0.348142:0.015979:0.008550:0.004773:0.003735:0.010687:0.005043:0.007969:0.010272:0.007948:0.004088:0.003735:0.014132:0.008010:0.005603:0.010376:0.006765:0.008218:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
118. Clevers, H. Modeling Development and Disease with Organoids. Cell 165, 1586–1597 :@0.117647:0.387241:0.856627:0.387241:0.856627:0.368720:0.117647:0.368720:0.009483:0.009483:0.009483:0.004088:0.004814:0.013406:0.004711:0.008487:0.008757:0.008218:0.006931:0.006973:0.004088:0.007740:0.015315:0.004088:0.007740:0.017243:0.010251:0.010293:0.008135:0.004773:0.005105:0.010417:0.008965:0.007740:0.014754:0.008485:0.008757:0.008137:0.004711:0.009834:0.010065:0.015898:0.008218:0.010355:0.005852:0.007740:0.008259:0.010542:0.010355:0.007740:0.014568:0.005105:0.007157:0.008446:0.008446:0.007159:0.008218:0.007740:0.013385:0.004792:0.006018:0.010417:0.007740:0.014817:0.006931:0.008965:0.008259:0.010542:0.009857:0.005043:0.010355:0.006973:0.004088:0.007740:0.013634:0.008135:0.004897:0.004773:0.007740:0.009483:0.009483:0.009483:0.004088:0.007740:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.003735
(2016).:@0.155000:0.407820:0.209639:0.407820:0.209639:0.389299:0.155000:0.389299:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
119. Kessler, M. :@0.117647:0.428399:0.242489:0.428399:0.242489:0.409878:0.117647:0.409878:0.009483:0.009483:0.009483:0.004088:0.004814:0.012700:0.008218:0.006848:0.006869:0.004711:0.008218:0.005686:0.004088:0.004503:0.017826:0.004088:0.003735
et al.:@0.243260:0.428399:0.279181:0.428399:0.279181:0.409687:0.243260:0.409687:0.007346:0.005727:0.004607:0.009048:0.004607:0.004586
 The Notch and Wnt pathways regulate stemness and differentiation in hu-:@0.279179:0.428399:0.852941:0.428399:0.852941:0.409878:0.279179:0.409878:0.004503:0.010428:0.010282:0.008218:0.004503:0.014111:0.009836:0.005644:0.007969:0.010417:0.004503:0.008259:0.010542:0.010355:0.004503:0.017099:0.010355:0.005852:0.004503:0.010334:0.008010:0.006018:0.010065:0.013385:0.008114:0.008840:0.006973:0.004503:0.006765:0.008218:0.008965:0.010500:0.004937:0.008010:0.005647:0.008218:0.004503:0.006829:0.005644:0.008218:0.016041:0.010542:0.008218:0.006846:0.006973:0.004503:0.008259:0.010542:0.010355:0.004503:0.010355:0.005105:0.005427:0.005258:0.008218:0.006765:0.008218:0.010355:0.005852:0.005271:0.008010:0.005852:0.005043:0.009857:0.010687:0.004503:0.005105:0.010687:0.004503:0.010085:0.010399:0.006848
man fallopian tube organoids. Nat. Commun. 6, 8989 (2015).:@0.155000:0.448977:0.621577:0.448977:0.621577:0.430456:0.155000:0.430456:0.015979:0.008259:0.010687:0.003735:0.005644:0.008550:0.004897:0.004711:0.009836:0.010065:0.005271:0.008259:0.010687:0.003735:0.005603:0.010314:0.010231:0.008218:0.003735:0.009855:0.006933:0.008965:0.008257:0.010544:0.009857:0.005043:0.010355:0.006973:0.004088:0.003735:0.014130:0.008010:0.005852:0.004088:0.003735:0.013634:0.009857:0.016041:0.015709:0.010376:0.010687:0.004088:0.003735:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
120. Sato, T. :@0.117647:0.469556:0.212772:0.469556:0.212772:0.451035:0.117647:0.451035:0.009483:0.009483:0.009483:0.004088:0.004814:0.009193:0.008010:0.005644:0.009338:0.004088:0.003715:0.009961:0.004088:0.003735
et al.:@0.212762:0.469556:0.247874:0.469556:0.247874:0.450844:0.212762:0.450844:0.007346:0.005727:0.003798:0.009048:0.004607:0.004586
 Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, :@0.247878:0.469556:0.856625:0.469556:0.856625:0.451035:0.247878:0.451035:0.003715:0.010749:0.009857:0.010417:0.008965:0.006848:0.005644:0.008218:0.007097:0.016041:0.003715:0.011061:0.009172:0.010334:0.008259:0.010563:0.006910:0.005043:0.009857:0.010687:0.003715:0.009857:0.005644:0.003715:0.010459:0.010065:0.004792:0.006018:0.010272:0.008137:0.004773:0.005269:0.008550:0.004773:0.003715:0.014817:0.006931:0.008965:0.008259:0.010542:0.009857:0.005043:0.010355:0.006973:0.003715:0.009774:0.006765:0.009857:0.016041:0.003715:0.014402:0.010376:0.015979:0.008259:0.010687:0.003715:0.013634:0.009940:0.004711:0.009857:0.010687:0.004088:0.003715:0.013032:0.010293:0.008218:0.010542:0.009857:0.015979:0.008446:0.004088:0.003735
Adenocarcinoma, and Barrett’s Epithelium. Gastroenterology 141, 1762–1772 (2011).:@0.155000:0.490135:0.807782:0.490135:0.807782:0.471614:0.155000:0.471614:0.013032:0.010293:0.008218:0.010542:0.010251:0.008280:0.008259:0.006765:0.008176:0.005105:0.010542:0.009857:0.015979:0.008446:0.004088:0.003735:0.008259:0.010542:0.010355:0.003735:0.011704:0.008259:0.007097:0.006765:0.008301:0.005603:0.004960:0.001577:0.006973:0.003735:0.010459:0.010065:0.004794:0.006018:0.010272:0.008135:0.004773:0.004792:0.010376:0.016041:0.004088:0.003735:0.014360:0.008446:0.006827:0.005852:0.006765:0.010251:0.008218:0.010355:0.005644:0.008218:0.006765:0.009940:0.004711:0.010044:0.009587:0.008840:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
121. Blokzijl, F. :@0.117647:0.510713:0.235765:0.510713:0.235765:0.492193:0.117647:0.492193:0.009483:0.009483:0.009483:0.004088:0.004814:0.011268:0.004711:0.009940:0.009566:0.008031:0.004794:0.004794:0.004524:0.004088:0.003320:0.007906:0.004088:0.003735
et al.:@0.235355:0.510713:0.270072:0.510713:0.270072:0.492001:0.235355:0.492001:0.007346:0.005727:0.003403:0.009048:0.004607:0.004586
 Tissue-specific mutation accumulation in human adult stem cells during life. :@0.270065:0.510713:0.856645:0.510713:0.856645:0.492193:0.270065:0.492193:0.003320:0.011579:0.005105:0.006848:0.006827:0.010314:0.008218:0.006848:0.006827:0.010459:0.008280:0.008176:0.005105:0.005167:0.005105:0.008176:0.003320:0.015709:0.010065:0.005956:0.008010:0.005852:0.005043:0.009857:0.010687:0.003320:0.008446:0.008176:0.008278:0.010376:0.015709:0.010500:0.004939:0.008010:0.005852:0.005043:0.009857:0.010687:0.003320:0.005105:0.010687:0.003320:0.010085:0.010376:0.015979:0.008259:0.010687:0.003320:0.008446:0.010042:0.010500:0.004462:0.005852:0.003320:0.006827:0.005644:0.008218:0.016041:0.003320:0.008176:0.008135:0.004897:0.004773:0.006973:0.003320:0.010044:0.010376:0.007097:0.005105:0.010417:0.008965:0.003320:0.004773:0.005105:0.005476:0.007948:0.004088:0.003735
Nature 538, 260–264 (2016).:@0.155000:0.531292:0.374116:0.531292:0.374116:0.512771:0.155000:0.512771:0.014132:0.008010:0.005603:0.010376:0.006765:0.008218:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
122. Drost, J. :@0.117647:0.551871:0.221696:0.551871:0.221696:0.533350:0.117647:0.533350:0.009483:0.009483:0.009483:0.004088:0.004814:0.014568:0.006765:0.009961:0.006827:0.005852:0.004088:0.005707:0.005105:0.004088:0.003735
et al.:@0.223673:0.551871:0.260818:0.551871:0.260818:0.533159:0.223673:0.533159:0.007346:0.005727:0.005831:0.009048:0.004607:0.004586
 Use of CRISPR-modified human stem cell organoids to study the origin of :@0.260822:0.551871:0.856639:0.551871:0.856639:0.533350:0.260822:0.533350:0.005707:0.013281:0.007159:0.008218:0.005707:0.009857:0.005644:0.005707:0.013343:0.012160:0.006599:0.008882:0.010604:0.011227:0.006848:0.015896:0.010251:0.010355:0.005105:0.005167:0.005103:0.008280:0.010355:0.005707:0.010085:0.010376:0.015979:0.008259:0.010687:0.005707:0.006827:0.005644:0.008218:0.016041:0.005707:0.008176:0.008135:0.004895:0.004773:0.005707:0.009857:0.006931:0.008965:0.008259:0.010542:0.009857:0.005043:0.010355:0.006973:0.005707:0.005644:0.010044:0.005707:0.006827:0.005603:0.010314:0.010293:0.008840:0.005707:0.006018:0.010272:0.008218:0.005707:0.009857:0.007097:0.005105:0.008965:0.005105:0.010687:0.005707:0.009857:0.005644:0.003735
mutational signatures in cancer. Science 358, 234–238 (2017).:@0.155000:0.572450:0.624981:0.572450:0.624981:0.553929:0.155000:0.553929:0.015709:0.010065:0.005956:0.008010:0.005852:0.005043:0.009857:0.010625:0.008550:0.004773:0.003735:0.006910:0.005105:0.008965:0.010625:0.008010:0.005603:0.010376:0.006765:0.008218:0.006973:0.003735:0.005105:0.010687:0.003735:0.008278:0.008259:0.010544:0.008176:0.008218:0.005684:0.004088:0.003735:0.009629:0.008176:0.005043:0.008218:0.010542:0.008176:0.008218:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
123. Drost, J. :@0.117647:0.593028:0.221063:0.593028:0.221063:0.574507:0.117647:0.574507:0.009483:0.009483:0.009483:0.004088:0.004814:0.014568:0.006765:0.009961:0.006827:0.005852:0.004088:0.005074:0.005105:0.004088:0.003735
et al.:@0.222402:0.593028:0.258904:0.593028:0.258904:0.574316:0.222402:0.574316:0.007346:0.005727:0.005188:0.009048:0.004607:0.004586
 Sequential cancer mutations in cultured human intestinal stem cells. Nature :@0.258902:0.593028:0.856678:0.593028:0.856678:0.574507:0.258902:0.574507:0.005074:0.009629:0.008280:0.009733:0.010314:0.008218:0.010355:0.005852:0.005271:0.008550:0.004773:0.005074:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.005074:0.015709:0.010065:0.005956:0.008010:0.005852:0.005043:0.009857:0.010563:0.006973:0.005074:0.005105:0.010687:0.005074:0.008280:0.010500:0.004462:0.005603:0.010376:0.006765:0.008280:0.010355:0.005074:0.010085:0.010376:0.015979:0.008261:0.010687:0.005074:0.005105:0.010355:0.005644:0.008218:0.006827:0.005852:0.005105:0.010627:0.008550:0.004773:0.005074:0.006827:0.005644:0.008218:0.016041:0.005074:0.008176:0.008135:0.004897:0.004773:0.006973:0.004088:0.005074:0.014132:0.008010:0.005603:0.010376:0.006765:0.008218:0.003735
521, 43–47 (2015).:@0.155000:0.613607:0.298311:0.613607:0.298311:0.595086:0.155000:0.595086:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.010729:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
124. Weeber, F. :@0.117647:0.634186:0.237467:0.634186:0.237467:0.615665:0.117647:0.615665:0.009483:0.009483:0.009483:0.004088:0.004814:0.016954:0.008280:0.008093:0.010231:0.008218:0.005686:0.004088:0.005188:0.007906:0.004088:0.003735
et al.:@0.238933:0.634186:0.275560:0.634186:0.275560:0.615474:0.238933:0.615474:0.007346:0.005727:0.005312:0.009048:0.004607:0.004586
 Preserved genetic diversity in organoids cultured from biopsies of human :@0.275558:0.634186:0.856601:0.634186:0.856601:0.615665:0.275558:0.615665:0.005188:0.010832:0.006765:0.008218:0.007157:0.008218:0.007637:0.008757:0.008280:0.010355:0.005188:0.008778:0.008218:0.010542:0.008301:0.005852:0.005043:0.008176:0.005188:0.010355:0.005043:0.008757:0.008218:0.006931:0.006910:0.004794:0.005852:0.008840:0.005188:0.005105:0.010687:0.005188:0.009857:0.006931:0.008965:0.008259:0.010542:0.009857:0.005043:0.010355:0.006973:0.005188:0.008280:0.010500:0.004462:0.005603:0.010376:0.006765:0.008278:0.010355:0.005188:0.005831:0.006765:0.009857:0.016041:0.005188:0.009836:0.005043:0.009836:0.010168:0.006910:0.005043:0.008218:0.006973:0.005188:0.009857:0.005644:0.005188:0.010085:0.010376:0.015979:0.008261:0.010687:0.003735
colorectal cancer metastases. Proc. Natl. Acad. Sci. U. S. A. 112, 13308–13311 (2015).:@0.155000:0.654764:0.799935:0.654764:0.799935:0.636244:0.155000:0.636244:0.008176:0.009940:0.004711:0.009857:0.006765:0.008280:0.008280:0.005956:0.008550:0.004773:0.003735:0.008278:0.008259:0.010544:0.008176:0.008218:0.007097:0.003735:0.015894:0.008301:0.005956:0.008446:0.006827:0.005956:0.008446:0.007159:0.008218:0.006973:0.004088:0.003735:0.010832:0.006765:0.010251:0.008176:0.004088:0.003735:0.014132:0.008010:0.006018:0.004524:0.004088:0.003735:0.013032:0.008278:0.008446:0.010106:0.004088:0.003735:0.009629:0.008176:0.004856:0.004088:0.003735:0.012638:0.004088:0.003735:0.009193:0.004088:0.003735:0.013572:0.004088:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
125. Roerink, S. F. :@0.117647:0.675343:0.261456:0.675343:0.261456:0.656822:0.117647:0.656822:0.009483:0.009483:0.009483:0.004088:0.004814:0.012451:0.010251:0.008218:0.007097:0.005105:0.010791:0.009566:0.004088:0.004939:0.009193:0.004088:0.004939:0.007906:0.004088:0.003735
et al.:@0.262677:0.675343:0.299055:0.675343:0.299055:0.656631:0.262677:0.656631:0.007346:0.005727:0.005063:0.009048:0.004607:0.004586
 Intra-tumour diversification in colorectal cancer at the single-cell level. :@0.299045:0.675343:0.856621:0.675343:0.856621:0.656822:0.299045:0.656822:0.004939:0.006267:0.010355:0.005852:0.007180:0.008446:0.006848:0.005603:0.010376:0.015896:0.009836:0.010376:0.007097:0.004939:0.010355:0.005043:0.008757:0.008218:0.006931:0.006910:0.005105:0.005167:0.005105:0.008280:0.008010:0.005852:0.005043:0.009857:0.010687:0.004939:0.005105:0.010687:0.004939:0.008176:0.009940:0.004711:0.009857:0.006765:0.008280:0.008280:0.005956:0.008550:0.004773:0.004939:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.004939:0.008010:0.005852:0.004939:0.006018:0.010272:0.008218:0.004939:0.006910:0.005105:0.010417:0.009027:0.004711:0.008218:0.006848:0.008176:0.008135:0.004897:0.004773:0.004939:0.004711:0.008487:0.008757:0.008135:0.004524:0.004088:0.003735
Nature 556, 457–462 (2018).:@0.155000:0.695922:0.374116:0.695922:0.374116:0.677401:0.155000:0.677401:0.014132:0.008010:0.005603:0.010376:0.006765:0.008218:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
126. Boj, S. F. :@0.117647:0.716500:0.225472:0.716500:0.225472:0.697980:0.117647:0.697980:0.009483:0.009483:0.009483:0.004088:0.004814:0.011891:0.009836:0.004524:0.004088:0.005561:0.009193:0.004088:0.005561:0.007906:0.004088:0.003735
et al.:@0.227320:0.716500:0.264320:0.716500:0.264320:0.697789:0.227320:0.697789:0.007346:0.005727:0.005686:0.009048:0.004607:0.004586
 Organoid models of human and mouse ductal pancreatic cancer. Cell 160, :@0.264325:0.716500:0.856598:0.716500:0.856598:0.697980:0.264325:0.697980:0.005561:0.014817:0.006931:0.008965:0.008259:0.010542:0.009857:0.005043:0.010355:0.005561:0.015896:0.010251:0.010293:0.008135:0.004773:0.006973:0.005561:0.009857:0.005644:0.005561:0.010085:0.010376:0.015979:0.008259:0.010687:0.005561:0.008259:0.010542:0.010355:0.005561:0.015896:0.009836:0.010376:0.007159:0.008218:0.005561:0.010044:0.010314:0.008280:0.005956:0.008550:0.004773:0.005561:0.010334:0.008259:0.010544:0.008176:0.006765:0.008444:0.008010:0.005852:0.005043:0.008176:0.005561:0.008280:0.008259:0.010542:0.008176:0.008218:0.005686:0.004088:0.005561:0.013634:0.008135:0.004897:0.004773:0.005561:0.009483:0.009483:0.009483:0.004088:0.003735
324–338 (2015).:@0.155000:0.737079:0.281004:0.737079:0.281004:0.718558:0.155000:0.718558:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
127. Gao, D. :@0.117647:0.757658:0.217815:0.757658:0.217815:0.739137:0.117647:0.739137:0.009483:0.009483:0.009483:0.004088:0.004814:0.014360:0.008446:0.009338:0.004088:0.005022:0.013738:0.004088:0.003735
et al.:@0.219104:0.757658:0.255552:0.757658:0.255552:0.738946:0.219104:0.738946:0.007346:0.005727:0.005134:0.009048:0.004607:0.004586
 Organoid cultures derived from patients with advanced prostate cancer. Cell :@0.255552:0.757658:0.856662:0.757658:0.856662:0.739137:0.255552:0.739137:0.005022:0.014817:0.006931:0.008965:0.008259:0.010542:0.009857:0.005043:0.010355:0.005022:0.008280:0.010500:0.004460:0.005605:0.010376:0.006765:0.008218:0.006973:0.005022:0.010293:0.008218:0.007097:0.005043:0.008757:0.008280:0.010355:0.005022:0.005829:0.006765:0.009859:0.016041:0.005022:0.010334:0.008010:0.005852:0.005043:0.008218:0.010355:0.005852:0.006973:0.005022:0.013385:0.004794:0.006018:0.010417:0.005022:0.008446:0.010293:0.008944:0.008259:0.010542:0.008176:0.008280:0.010355:0.005022:0.010065:0.006765:0.009961:0.006827:0.005956:0.008010:0.005644:0.008218:0.005022:0.008280:0.008259:0.010542:0.008176:0.008218:0.005686:0.004088:0.005022:0.013632:0.008135:0.004897:0.004773:0.003735
159, 176–187 (2014).:@0.155000:0.778237:0.317278:0.778237:0.317278:0.759716:0.155000:0.759716:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
128. van de Wetering, M. :@0.117647:0.798815:0.315368:0.798815:0.315368:0.780294:0.117647:0.780294:0.009483:0.009483:0.009483:0.004088:0.004814:0.008944:0.008259:0.010687:0.004565:0.010293:0.008218:0.004565:0.016954:0.008301:0.005644:0.008218:0.007097:0.005105:0.010417:0.008799:0.004088:0.004565:0.017826:0.004088:0.003735
et al.:@0.316200:0.798815:0.352183:0.798815:0.352183:0.780103:0.316200:0.780103:0.007346:0.005727:0.004669:0.009048:0.004607:0.004586
 Prospective derivation of a living organoid biobank of colorectal :@0.352181:0.798815:0.856676:0.798815:0.856676:0.780294:0.352181:0.780294:0.004565:0.010832:0.006765:0.009961:0.006827:0.010459:0.008280:0.008280:0.005852:0.005043:0.008757:0.008218:0.004565:0.010293:0.008218:0.007097:0.005043:0.008944:0.008010:0.005852:0.005043:0.009857:0.010687:0.004565:0.009857:0.005644:0.004565:0.008446:0.004565:0.004773:0.005043:0.008944:0.005105:0.010417:0.008965:0.004565:0.009857:0.006931:0.008965:0.008259:0.010544:0.009857:0.005043:0.010355:0.004565:0.009836:0.005043:0.009961:0.010106:0.008259:0.010791:0.009566:0.004565:0.009857:0.005644:0.004565:0.008176:0.009940:0.004711:0.009857:0.006765:0.008280:0.008280:0.005956:0.008550:0.004773:0.003735
cancer patients. Cell 161, 933–945 (2015).:@0.155000:0.819394:0.475216:0.819394:0.475216:0.800873:0.155000:0.800873:0.008280:0.008259:0.010542:0.008176:0.008218:0.007097:0.003735:0.010334:0.008010:0.005852:0.005043:0.008218:0.010355:0.005852:0.006973:0.004088:0.003735:0.013632:0.008135:0.004897:0.004773:0.003735:0.009483:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
129. Fujii, M. :@0.117647:0.839973:0.226043:0.839973:0.226043:0.821452:0.117647:0.821452:0.009483:0.009483:0.009483:0.004088:0.004814:0.009753:0.010065:0.004794:0.005105:0.004856:0.004088:0.006734:0.017826:0.004088:0.003735
et al.:@0.229044:0.839973:0.267248:0.839973:0.267248:0.821261:0.229044:0.821261:0.007346:0.005727:0.006890:0.009048:0.004607:0.004586
 A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of :@0.267243:0.839973:0.856751:0.839973:0.856751:0.821452:0.267243:0.821452:0.006744:0.013572:0.006744:0.013632:0.009942:0.004711:0.009857:0.006765:0.008278:0.008280:0.005956:0.008550:0.004773:0.006744:0.009919:0.010376:0.015896:0.009857:0.007097:0.006744:0.014817:0.006931:0.008965:0.008259:0.010542:0.009857:0.005043:0.010355:0.006744:0.010666:0.005043:0.009836:0.007178:0.008261:0.007635:0.008840:0.006744:0.014754:0.008218:0.015896:0.009857:0.010563:0.006827:0.005852:0.007180:0.008010:0.005644:0.008218:0.006973:0.006744:0.010832:0.006765:0.010044:0.008965:0.006765:0.008218:0.006848:0.006910:0.005043:0.008757:0.008218:0.006744:0.010749:0.009961:0.006848:0.006973:0.006744:0.009857:0.005644:0.003735
Niche Factor Requirements during Tumorigenesis. Cell Stem Cell 18, 827–838 (2016).:@0.155000:0.860551:0.811515:0.860551:0.811515:0.842031:0.155000:0.842031:0.014277:0.005043:0.007969:0.010272:0.008218:0.003735:0.009753:0.008446:0.008280:0.005644:0.009857:0.007097:0.003735:0.012451:0.008280:0.009733:0.010376:0.005105:0.006765:0.008218:0.015894:0.008218:0.010355:0.005852:0.006973:0.003735:0.010044:0.010376:0.007097:0.005105:0.010417:0.008965:0.003735:0.009919:0.010376:0.015896:0.009857:0.007097:0.005105:0.008778:0.008218:0.010542:0.008218:0.006910:0.005105:0.006973:0.004088:0.003735:0.013634:0.008135:0.004897:0.004773:0.003735:0.008902:0.005644:0.008218:0.016041:0.003735:0.013632:0.008135:0.004897:0.004773:0.003735:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088
130. Huang, L. :@0.117647:0.881130:0.235267:0.881130:0.235267:0.862609:0.117647:0.862609:0.009483:0.009483:0.009483:0.004088:0.004814:0.014402:0.010542:0.008259:0.010417:0.008799:0.004088:0.005375:0.010563:0.004088:0.003735
et al.:@0.236905:0.881130:0.273718:0.881130:0.273718:0.862418:0.236905:0.862418:0.007346:0.005727:0.005499:0.009048:0.004607:0.004586
 Ductal pancreatic cancer modeling and drug screening using human plu-:@0.273711:0.881130:0.852941:0.881130:0.852941:0.862609:0.273711:0.862609:0.005375:0.014754:0.010314:0.008280:0.005954:0.008550:0.004773:0.005375:0.010334:0.008259:0.010542:0.008176:0.006765:0.008446:0.008010:0.005852:0.005043:0.008176:0.005375:0.008280:0.008259:0.010544:0.008176:0.008218:0.007097:0.005375:0.015896:0.010251:0.010293:0.008135:0.004773:0.005105:0.010417:0.008965:0.005375:0.008259:0.010542:0.010355:0.005375:0.010355:0.007242:0.010376:0.008965:0.005375:0.007159:0.008176:0.006765:0.008280:0.008218:0.010687:0.005105:0.010415:0.008965:0.005375:0.010376:0.006910:0.005105:0.010417:0.008965:0.005375:0.010085:0.010376:0.015979:0.008259:0.010687:0.005375:0.010148:0.004462:0.010368:0.006848
ripotent stem cell- and patient-derived tumor organoids. Nat. Med. 21, 1364–1371 (2015).:@0.155000:0.901709:0.841397:0.901709:0.841397:0.883188:0.155000:0.883188:0.007097:0.004794:0.010459:0.009836:0.005644:0.008218:0.010355:0.005852:0.003735:0.006827:0.005644:0.008218:0.016041:0.003735:0.008176:0.008133:0.004899:0.004773:0.006848:0.003735:0.008257:0.010542:0.010355:0.003735:0.010334:0.008010:0.005852:0.005043:0.008218:0.010355:0.005852:0.006848:0.010293:0.008218:0.007097:0.005043:0.008757:0.008280:0.010355:0.003735:0.005603:0.010376:0.015896:0.009857:0.007097:0.003735:0.009857:0.006931:0.008965:0.008259:0.010542:0.009857:0.005043:0.010355:0.006973:0.004088:0.003735:0.014132:0.008010:0.005852:0.004088:0.003735:0.017243:0.008280:0.010106:0.004088:0.003735:0.009483:0.009483:0.004088:0.003735:0.009483:0.009483:0.009483:0.009483:0.010729:0.009483:0.009483:0.009483:0.009483:0.003735:0.006308:0.009483:0.009483:0.009483:0.009483:0.006308:0.004088